These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 31385885

  • 1. Efficacy of the Combination of Pinaverium Bromide 100 mg Plus Simethicone 300 mg in Abdominal Pain and Bloating in Irritable Bowel Syndrome: A Randomized, Placebo-controlled Trial.
    Schmulson MJ, Chiu-Ugalde J, Sáez-Ríos A, López-Colombo A, Mateos-Pérez GJ, Remes-Troche JM, Sobrino-Cossio S, Soto-Pérez JC, Tamayo de la Cuesta JL, Teramoto-Matsubara OT, López-Alvarenga JC.
    J Clin Gastroenterol; 2020 Apr; 54(4):e30-e39. PubMed ID: 31385885
    [Abstract] [Full Text] [Related]

  • 2. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
    Urgesi R, Casale C, Pistelli R, Rapaccini GL, de Vitis I.
    Eur Rev Med Pharmacol Sci; 2014 Apr; 18(9):1344-53. PubMed ID: 24867512
    [Abstract] [Full Text] [Related]

  • 3. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
    Holvoet T, Joossens M, Vázquez-Castellanos JF, Christiaens E, Heyerick L, Boelens J, Verhasselt B, van Vlierberghe H, De Vos M, Raes J, De Looze D.
    Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
    [Abstract] [Full Text] [Related]

  • 4. Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points.
    Lacy BE, Chang L, Rao SSC, Heimanson Z, Sayuk GS.
    Clin Ther; 2023 Mar; 45(3):198-209. PubMed ID: 36922331
    [Abstract] [Full Text] [Related]

  • 5. Polar vectors as a method for evaluating the effectiveness of irritable bowel syndrome treatments: an analysis with pinaverium bromide 100mg plus simethicone 300mg po bid.
    López-Alvarenga JC, Sobrino-Cossío S, Remes-Troche JM, Chiu-Ugalde J, Vargas-Romero JA, Schmulson M.
    Rev Gastroenterol Mex; 2013 Mar; 78(1):21-7. PubMed ID: 23375823
    [Abstract] [Full Text] [Related]

  • 6. Pinaverium Reduces Symptoms of Irritable Bowel Syndrome in a Multicenter, Randomized, Controlled Trial.
    Zheng L, Lai Y, Lu W, Li B, Fan H, Yan Z, Gong C, Wan X, Wu J, Huang D, Wang Y, Mei Y, Li Z, Jiang Z, Liu X, Ye J, Yang Y, Huang H, Xiao J.
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1285-1292.e1. PubMed ID: 25632806
    [Abstract] [Full Text] [Related]

  • 7. Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis.
    Cayzeele-Decherf A, Pélerin F, Leuillet S, Douillard B, Housez B, Cazaubiel M, Jacobson GK, Jüsten P, Desreumaux P.
    World J Gastroenterol; 2017 Jan 14; 23(2):336-344. PubMed ID: 28127207
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.
    Weerts ZZRM, Masclee AAM, Witteman BJM, Clemens CHM, Winkens B, Brouwers JRBJ, Frijlink HW, Muris JWM, De Wit NJ, Essers BAB, Tack J, Snijkers JTW, Bours AMH, de Ruiter-van der Ploeg AS, Jonkers DMAE, Keszthelyi D.
    Gastroenterology; 2020 Jan 14; 158(1):123-136. PubMed ID: 31470006
    [Abstract] [Full Text] [Related]

  • 9. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.
    Aliment Pharmacol Ther; 2005 Feb 15; 21(4):435-44. PubMed ID: 15709995
    [Abstract] [Full Text] [Related]

  • 10. Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study.
    Wittmann T, Paradowski L, Ducrotté P, Bueno L, Andro Delestrain MC.
    Aliment Pharmacol Ther; 2010 Mar 15; 31(6):615-24. PubMed ID: 20003095
    [Abstract] [Full Text] [Related]

  • 11. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
    Clavé P, Acalovschi M, Triantafillidis JK, Uspensky YP, Kalayci C, Shee V, Tack J, OBIS Study Investigators.
    Aliment Pharmacol Ther; 2011 Aug 15; 34(4):432-42. PubMed ID: 21679214
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.
    Vázquez-Frias R, Consuelo-Sánchez A, Acosta-Rodríguez-Bueno CP, Blanco-Montero A, Robles DC, Cohen V, Márquez D, Perez M.
    Paediatr Drugs; 2023 Jan 15; 25(1):115-126. PubMed ID: 36380186
    [Abstract] [Full Text] [Related]

  • 13. Tongxie Formula Reduces Symptoms of Irritable Bowel Syndrome.
    Fan H, Zheng L, Lai Y, Lu W, Yan Z, Xiao Q, Li B, Tang M, Huang D, Wang Y, Li Z, Mei Y, Jiang Z, Liu X, Tang Q, Zuo D, Ye J, Yang Y, Huang H, Tang Z, Xiao J, China Irritable Bowel Syndrome Consortium.
    Clin Gastroenterol Hepatol; 2017 Nov 15; 15(11):1724-1732. PubMed ID: 28634136
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trial.
    Anderle K, Wolzt M, Moser G, Keip B, Peter J, Meisslitzer C, Gouya G, Freissmuth M, Tschegg C.
    World J Gastroenterol; 2022 Dec 14; 28(46):6573-6588. PubMed ID: 36569277
    [Abstract] [Full Text] [Related]

  • 15. Otilonium bromide in irritable bowel syndrome: a dose-ranging randomized double-blind placebo-controlled trial.
    Chmielewska-Wilkoń D, Reggiardo G, Egan CG.
    World J Gastroenterol; 2014 Sep 14; 20(34):12283-91. PubMed ID: 25232263
    [Abstract] [Full Text] [Related]

  • 16. Octatropine methyl bromide and diazepam combination (Valpinax) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial.
    Pace F, Maurano A, Ciacci C, Savarino V, Attili A, Iaquinto G, Magni E, Porro GB.
    Eur Rev Med Pharmacol Sci; 2010 Mar 14; 14(3):155-62. PubMed ID: 20391952
    [Abstract] [Full Text] [Related]

  • 17. Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults.
    Kemppinen A, Howell C, Allgar V, Dodd M, Gregson J, Knowles C, McLaughlin J, Pandya P, Whorwell P, Markaryan E, Yiannakou Y.
    Trials; 2020 Jan 30; 21(1):122. PubMed ID: 32000822
    [Abstract] [Full Text] [Related]

  • 18. The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study.
    Faghih Dinevari M, Jafarzadeh F, Jabbaripour Sarmadian A, Abbasian S, Nikniaz Z, Riazi A.
    BMC Gastroenterol; 2023 Apr 25; 23(1):135. PubMed ID: 37098505
    [Abstract] [Full Text] [Related]

  • 19. Combination of a Probiotic and an Antispasmodic Increases Quality of Life and Reduces Symptoms in Patients with Irritable Bowel Syndrome: A Pilot Study.
    Barraza-Ortiz DA, Pérez-López N, Medina-López VM, Minero-Alfaro JI, Zamarripa-Dorsey F, Fernández-Martínez NDC, Llorente-Ramón A, Ramos-Aguilar GA.
    Dig Dis; 2021 Apr 25; 39(3):294-300. PubMed ID: 32810850
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.
    Choi CH, Kwon JG, Kim SK, Myung SJ, Park KS, Sohn CI, Rhee PL, Lee KJ, Lee OY, Jung HK, Jee SR, Jeen YT, Choi MG, Choi SC, Huh KC, Park H.
    Neurogastroenterol Motil; 2015 May 25; 27(5):705-16. PubMed ID: 25809913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.